Position in NRIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$187,686,398
+$89,335,116 QoQ
Shares Held
7,736,455
+21.9% QoQ
Ownership
7.45%
of shares outstanding
% of Portfolio
2.86%
of 13F equity value
Holder Rank
#3
of 210 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Deep Track Capital, LP holds $5,341,997,223 across 58 Biotechnology names. NRIX ranks #9 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMVT |
Immunovant, Inc.
|
9,341,151 | $359,914,548 | |
| 2 | GPCR |
Structure Therapeutics Inc.
|
4,740,072 | $254,399,664 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
4,300,000 | $249,959,000 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
825,000 | $248,349,750 | |
| 5 | MANE |
Veradermics, Inc
|
2,000,000 | $245,880,000 | |
| 6 | TARS |
Tarsus Pharmaceuticals, Inc.
|
3,666,768 | $230,786,377 | |
| 7 | OCUL |
Ocular Therapeutix, Inc
|
19,686,282 | $193,319,289 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
3,307,481 | $189,254,062 |
All Filings in NRIX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $187,686,398 | 7,736,455 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $187,686,398 | 7,736,455 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $98,351,282 | 6,345,244 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $133,481,551 | 7,036,455 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $55,966,901 | 6,057,024 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $69,079,324 | 6,064,910 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $65,340,000 | 5,500,000 | Shares | Sole | 2025-05-15 | |
| 2025-02-07 | $77,880,000 | 4,125,000 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $56,520,000 | 3,000,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $86,916,296 | 3,868,104 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $83,302,605 | 3,991,500 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $44,068,101 | 2,997,830 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $30,937,605 | 2,997,830 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $23,562,943 | 2,997,830 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $29,948,321 | 2,997,830 | Shares | Sole | 2023-09-06 | |
| 2023-03-31 | $26,620,730 | 2,997,830 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $24,886,927 | 2,266,569 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $26,758,681 | 2,053,621 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $30,866,197 | 2,436,164 | Shares | Sole | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||